IGF1 and Parkinson disease: Moreover, IGF1 protects cells against the PD-inducing neurotoxin, associated with the activation of glycogen synthase 3 kinase (GSK3) [33], and the reduction in the levels of α-syn aggregation through activation of the phosphoinositide 3 kinase (PI3K) and AKT pathway [34].